Literature DB >> 14521480

Combination strategies for pain management.

Robert B Raffa1, Rachel Clark-Vetri, Ronald J Tallarida, Albert I Wertheimer.   

Abstract

At least two factors relating to pain management using oral analgesics suggest that combination strategies merit consideration: many pains arise from more than one physiological cause and current analgesics have adverse effect profiles that might be reduced by combination with another agent in smaller doses or with less frequent dosing. In addition to increased convenience, combinations sometimes also result in the unexpected benefit of synergy. But not all pains, clinical settings or combinations merit the extra expense or other potential negative features of fixed-ratio products. This review examines the multiple basic science, clinical and pharmacoeconomic issues relating to analgesic combinations and the methodologies available for assessing these issues.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14521480     DOI: 10.1517/14656566.4.10.1697

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  21 in total

Review 1.  The determination and application of fixed-dose analgesic combinations for treating multimodal pain.

Authors:  Robert B Raffa; Joseph V Pergolizzi; Ronald J Tallarida
Journal:  J Pain       Date:  2010-03-24       Impact factor: 5.820

2.  Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice.

Authors:  Shao M Tham; James A Angus; Elizabeth M Tudor; Christine E Wright
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

3.  Combinations of intrathecal gamma-amino-butyrate receptor agonists and N-methyl-d-aspartate receptor antagonists in rats with neuropathic spinal cord injury pain.

Authors:  Aldric Hama; Jacqueline Sagen
Journal:  Eur J Pharmacol       Date:  2012-03-16       Impact factor: 4.432

4.  The opioid rotation ratio of hydrocodone to strong opioids in cancer patients.

Authors:  Akhila Reddy; Sriram Yennurajalingam; Hem Desai; Suresh Reddy; Maxine de la Cruz; Jimin Wu; Diane Liu; Eden Mae Rodriguez; Jessica Waletich; Seong Hoon Shin; Vicki Gayle; Pritul Patel; Shalini Dalal; Marieberta Vidal; Kimberson Tanco; Joseph Arthur; Kimmie Tallie; Janet Williams; Julio Silvestre; Eduardo Bruera
Journal:  Oncologist       Date:  2014-10-23

Review 5.  The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations.

Authors:  Ronald J Tallarida; Robert B Raffa
Journal:  Pharmacol Ther       Date:  2010-05-28       Impact factor: 12.310

6.  In vivo and in vitro sensitivity of Fasciola hepatica to triclabendazole combined with artesunate, artemether, or OZ78.

Authors:  Urs Duthaler; Thomas A Smith; Jennifer Keiser
Journal:  Antimicrob Agents Chemother       Date:  2010-08-23       Impact factor: 5.191

Review 7.  Tramadol/paracetamol fixed-dose combination: a review of its use in the management of moderate to severe pain.

Authors:  Sohita Dhillon
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

Review 8.  Pain management today - what have we learned?

Authors:  Richard M Langford
Journal:  Clin Rheumatol       Date:  2006-06-02       Impact factor: 2.980

Review 9.  The mu-opioid receptor agonist/noradrenaline reuptake inhibition (MOR-NRI) concept in analgesia: the case of tapentadol.

Authors:  Thomas M Tzschentke; Thomas Christoph; Babette Y Kögel
Journal:  CNS Drugs       Date:  2014-04       Impact factor: 5.749

10.  Aceclofenac-tizanidine in the treatment of acute low back pain: a double-blind, double-dummy, randomized, multicentric, comparative study against aceclofenac alone.

Authors:  Anil Pareek; Nitin Chandurkar; A S Chandanwale; Ratnakar Ambade; Anil Gupta; Girish Bartakke
Journal:  Eur Spine J       Date:  2009-05-07       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.